LIMINATUS PHARM Price to Sales Ratio 1971-1970 | LIMN
Historical PS ratio values for LIMINATUS PHARM (LIMN) over the last 10 years. The current P/S ratio for LIMINATUS PHARM as of May 07, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| LIMINATUS PHARM P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-07 | 6.00 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED-DRUGS | $0.000B | $0.000B |
| Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Flowco Holdings (FLOC) | United States | $1.886B | 0.00 |
| Oaktree Acquisition III Life Sciences (OACC) | United States | $0.235B | 0.00 |
| Aduro Clean Technologies (ADUR) | Canada | $0.157B | 0.00 |
| Range Capital Acquisition (RANG) | United States | $0.144B | 0.00 |
| Tavia Acquisition (TAVI) | $0.141B | 0.00 | |
| YSX Tech (YSXT) | China | $0.099B | 0.00 |
| CO2 Energy Transition (NOEM) | United States | $0.096B | 0.00 |
| Leishen Energy Holding (LSE) | China | $0.092B | 0.00 |
| YHN Acquisition I (YHNA) | $0.082B | 0.00 | |
| Youxin Technology (YAAS) | China | $0.040B | 0.00 |
| New Century Logistics (BVI) (NCEW) | Hong Kong, SAR China | $0.035B | 0.00 |
| Sky Quarry (SKYQ) | United States | $0.015B | 0.00 |
| PicoCELA (PCLA) | Japan | $0.011B | 0.00 |
| Hong Kong Pharma Digital Technology Holdings (HKPD) | $0.010B | 0.00 | |
| SMART DGTL GRP (SDM) | $0.000B | 0.00 | |
| WINCHESTER BCP (WSBK) | $0.000B | 0.00 | |
| YUANBAO INC (YB) | China | $0.000B | 0.00 |
| CANTOR EQ PT II (CEPT) | $0.000B | 0.00 |